Bulletin from extraordinary general meeting of BioPhausia AB (publ) 30 August 2010

| Source: BioPhausia AB BioPhausia AB 

At an extraordinary general meeting of BioPhausia AB (publ) today, the following
resolutions have been made:

Today's extraordinary general meeting approved the sale of all shares of the
Dutch subsidiary AllGen Pharmaceuticals and Generics B.V to Ostwald Beheer B.V.
The transaction requires approval of the general meeting according to Chapter
16 of the Companies Act, since Ostwald Beheer B.V is owned by Mr Eric Jan
Ostwald, who is the managing director of AllGen Pharmaceuticals and Generics
B.V. The decision of the general meeting was unanimous.

Stockholm, August 30, 2010

For further information contact: Niklas Prager, Chairman, tel +46(0)76-811 77 44


The information must be made public according to the Securities Markets Act
(Sw. Lag om värdepappersmarknaden) and/or the Financial Instruments Trading Act
(Sw. Lag om handel med finansiella instrument).


[HUG#1441239]

Attachments

Bulletin from extraordinary general meeting of BioPhausia AB publ 30 August 2010.pdf